{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T06:25:33Z","timestamp":1771655133491,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004621","name":"Kerman University of Medical Sciences","doi-asserted-by":"publisher","award":["94.161"],"award-info":[{"award-number":["94.161"]}],"id":[{"id":"10.13039\/501100004621","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.intimp.2019.02.008","type":"journal-article","created":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T06:07:16Z","timestamp":1550124436000},"page":"321-327","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Host's immune response in unresponsive and responsive patients with anthroponotic cutaneous leishmaniasis treated by meglumine antimoniate: A case-control study of Th1 and Th2 pathways"],"prefix":"10.1016","volume":"69","author":[{"given":"Mehdi","family":"Bamorovat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iraj","family":"Sharifi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Reza","family":"Aflatoonian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Balal","family":"Sadeghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alireza","family":"Shafiian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Razieh Tavakoli","family":"Oliaee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alireza","family":"Keyhani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abbas Aghaei","family":"Afshar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmad","family":"Khosravi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahshid","family":"Mostafavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam Hakimi","family":"Parizi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7519-6998","authenticated-orcid":false,"given":"Mehrdad","family":"Khatami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nasir","family":"Arefinia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2019.02.008_bb0005","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.actatropica.2011.04.007","article-title":"Studies on the protective efficacy and immunogenicity of Hsp70 and Hsp83 based vaccine formulations in Leishmania donovani infected BALB\/c mice","volume":"119","author":"Kaur","year":"2011","journal-title":"Acta Trop."},{"key":"10.1016\/j.intimp.2019.02.008_bb0010","doi-asserted-by":"crossref","unstructured":"P. Desjeux, The increase in risk factors for leishmaniasis worldwide., Trans. R. Soc. Trop. Med. Hyg.. 95 (2004) 239\u201343.","DOI":"10.1016\/S0035-9203(01)90223-8"},{"key":"10.1016\/j.intimp.2019.02.008_bb0015","doi-asserted-by":"crossref","DOI":"10.1038\/nri.2016.72","article-title":"Cutaneous leishmaniasis: immune responses in protection and pathogenesis","author":"Scott","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2019.02.008_bb0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005739","article-title":"A new perspective on cutaneous leishmaniasis-Implication for global prevalence and burden of diseases estimates","volume":"11","author":"Bailey","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.intimp.2019.02.008_bb0025","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.3109\/14767058.2015.1048431","article-title":"The use of angiogenic biomarkers in maternal blood to identify which SGA fetuses will require a preterm delivery and mothers who will develop pre-eclampsia","volume":"29","author":"Chaiworapongsa","year":"2016","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"10.1016\/j.intimp.2019.02.008_bb0030","doi-asserted-by":"crossref","unstructured":"R.O. Dillman, Cancer immunotherapy, Cancer Biother. Radiopharm.. 26 (2011) 1\u201364.","DOI":"10.1089\/cbr.2010.0902"},{"key":"10.1016\/j.intimp.2019.02.008_bb0035","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.2174\/1381612033454685","article-title":"Low-cost anti-HIV compounds: potential application for AIDS therapy in developing countries","volume":"9","author":"Bourinbaiar","year":"2003","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.intimp.2019.02.008_bb0040","series-title":"Control of the Leishmaniases: Report of a Meeting of the WHO Expert Committee on the Control of Leishmaniases","first-page":"1","article-title":"Control of the leishmaniases: Report of a meeting of the WHO expert committee on the control of leishmaniases","author":"WHO","year":"2010"},{"key":"10.1016\/j.intimp.2019.02.008_bb0045","doi-asserted-by":"crossref","unstructured":"Y. Dowlati, Cutaneous leishmaniasis: clinical aspect, Clin. Dermatol.. 14 (1996) 425\u2013431.","DOI":"10.1016\/0738-081X(96)00058-2"},{"key":"10.1016\/j.intimp.2019.02.008_bb0050","doi-asserted-by":"crossref","unstructured":"M. Bamorovat, I. Sharifi, M.R. Aflatoonian, H. Sharifi, A. Karamoozian, F. Sharifi, A. Khosravi, S. Hassanzadeh, Risk factors for anthroponotic cutaneous leishmaniasis in unresponsive and responsive patients in a major focus, southeast of Iran, PLoS One. 13 (2018) e0192236.","DOI":"10.1371\/journal.pone.0192236"},{"key":"10.1016\/j.intimp.2019.02.008_bb0055","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.micpath.2018.01.021","article-title":"Leishmania tropica isolates from non-healed and healed patients in Iran: a molecular typing and phylogenetic analysis","volume":"116","author":"Bamorovat","year":"2018","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.intimp.2019.02.008_bb0060","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1093\/clinids\/20.5.1207","article-title":"Disseminated Acanthamoeba infection in patients with AIDS: case reports and review","volume":"20","author":"Sison","year":"1995","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.intimp.2019.02.008_bb0065","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1574-695X.1999.tb01397.x","article-title":"Immune dysfunction in patients with diabetes mellitus (DM)","volume":"26","author":"Geerlings","year":"1999","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"10.1016\/j.intimp.2019.02.008_bb0070","doi-asserted-by":"crossref","unstructured":"J.M. Blackwell, Genetic susceptibility to leishmanial infections: studies in mice and man, Parasitology. 112 (1996) S67\u2013S74.","DOI":"10.1017\/S0031182000076678"},{"key":"10.1016\/j.intimp.2019.02.008_bb0075","doi-asserted-by":"crossref","unstructured":"A. Ponte-Sucre, E. Diaz, M. Padr\u00f3n-Nieves, Drug Resistance in Leishmania Parasites: Consequences, Molecular Mechanisms and Possible Treatments, Springer Science & Business Media, 2012.","DOI":"10.1007\/978-3-7091-1125-3"},{"key":"10.1016\/j.intimp.2019.02.008_bb0080","doi-asserted-by":"crossref","unstructured":"A. Ponte-Sucre, F. Gamarro, J.-C. Dujardin, M.P. Barrett, R. L\u00f3pez-V\u00e9lez, R. Garc\u00eda-Hern\u00e1ndez, A.W. Pountain, R. Mwenechanya, B. Papadopoulou, Drug resistance and treatment failure in leishmaniasis: a 21st century challenge, PLoS Negl. Trop. Dis.. 11 (2017) e0006052.","DOI":"10.1371\/journal.pntd.0006052"},{"key":"10.1016\/j.intimp.2019.02.008_bb0085","doi-asserted-by":"crossref","unstructured":"M.T.M. Roberts, Current understandings on the immunology of leishmaniasis and recent developments in prevention and treatment, Br. Med. Bull.. 75 (2005) 115\u2013130.","DOI":"10.1093\/bmb\/ldl003"},{"key":"10.1016\/j.intimp.2019.02.008_bb0090","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1086\/653829","article-title":"T-bet, GATA-3, and Foxp3 expression and Th1\/Th2 cytokine production in the clinical outcome of human infection with Leishmania (Viannia) species","volume":"202","author":"D\u00edaz","year":"2010","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.intimp.2019.02.008_bb0095","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/j.intimp.2011.08.002","article-title":"Immunomodulation by chemotherapeutic agents against Leishmaniasis","volume":"11","author":"Saha","year":"2011","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2019.02.008_bb0100","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.intimp.2008.03.016","article-title":"Immunoregulatory mechanisms and CD4\u2212 CD8\u2212(double negative) T cell subpopulations in human cutaneous leishmaniasis: a balancing act between protection and pathology","volume":"8","author":"Gollob","year":"2008","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2019.02.008_bb0105","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/j.intimp.2008.07.011","article-title":"Meglumine antimonate directly increases phagocytosis, superoxide anion and TNF-\u03b1 production, but only via TNF-\u03b1 it indirectly increases nitric oxide production by phagocytes of healthy individuals, in vitro","volume":"8","author":"Muniz-Junqueira","year":"2008","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2019.02.008_bb0110","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1128\/IAI.68.4.1760-1764.2000","article-title":"Comparison of the immune profile of nonhealing cutaneous leishmaniasis patients with those with active lesions and those who have recovered from infection","volume":"68","author":"Ajdary","year":"2000","journal-title":"Infect. Immun."},{"key":"10.1016\/j.intimp.2019.02.008_bb0115","doi-asserted-by":"crossref","unstructured":"H. Louzir, P.C. Melby, A. Ben Salah, H. Marrakchi, K. Aoun, R. Ben Ismail, K. Dellagi, Immunologic determinants of disease evolution in localized cutaneous leishmaniasis due to Leishmania major, J. Infect. Dis.. 177 (1998) 1687\u20131695.","DOI":"10.1086\/515297"},{"key":"10.1016\/j.intimp.2019.02.008_bb0120","doi-asserted-by":"crossref","unstructured":"A. Ribeiro-de-Jesus, R.P. de Almeida, H. Lessa, O. Bacellar, E.M. Carvalho, Cytokine profile and pathology in human leishmaniasis, Braz. J. Med. Biol. Res.. 31 (1998) 143\u2013148.","DOI":"10.1590\/S0100-879X1998000100020"},{"key":"10.1016\/j.intimp.2019.02.008_bb0125","unstructured":"M.R. Aflatoonian, I. Sharifi, B. Aflatoonian, M.R. Shirzadi, M.M. Gouya, A. Kermanizadeh, A review of impact of bam earthquake on cutaneous leishmaniasis and status: epidemic of old foci, emergence of new foci and changes in features of the disease, J. Arthropod. Borne Dis.. 10 (2016) 271."},{"key":"10.1016\/j.intimp.2019.02.008_bb0130","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212 \u0394\u0394CT method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.intimp.2019.02.008_bb0135","unstructured":"I. Sharifi, M.R. Aflatoonian, A.R. Fekri, M. Hakimi Parizi, A. Aghaei Afshar, A. Khosravi, F. Sharifi, B. Aflatoonian, A. Khamesipour, Y. Dowlati, F. Modabber, A. Nadim, A comprehensive review of cutaneous leishmaniasis in Kerman province, southeastern Iran-narrative review article., Iran. J. Public Health. 44 (2015) 299\u2013307."},{"key":"10.1016\/j.intimp.2019.02.008_bb0140","doi-asserted-by":"crossref","unstructured":"R. Hadighi, M. Mohebali, P. Boucher, H. Hajjaran, A. Khamesipour, M. Ouellette, Unresponsiveness to Glucantime treatment in Iranian cutaneous leishmaniasis due to drug-resistant Leishmania tropica parasites, PLoS Med. 3 (2006) e162.","DOI":"10.1371\/journal.pmed.0030162"},{"key":"10.1016\/j.intimp.2019.02.008_bb0145","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1086\/503371","article-title":"Resistance to antimony and treatment failure in human Leishmania (Viannia) infection","volume":"193","author":"Rojas","year":"2006","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.intimp.2019.02.008_bb0150","unstructured":"J.M. Mutiso, J.C. Macharia, M.M. Gicheru, H. Ozwara, B. Moodi, M. Aliabadian, A. Moshaverinia, O.M. Kakhki, A. Chaudhary, C. Verma, Immunology of leishmaniasis, Sci. Parasitol.. 14 (2013) 51\u201361."},{"key":"10.1016\/j.intimp.2019.02.008_bb0155","doi-asserted-by":"crossref","unstructured":"C.A. Nacy, M.S. Meltzer, E.J. Leonard, D.J. Wyler, Intracellular replication and lymphokine-induced destruction of Leishmania tropica in C3H\/HeN mouse macrophages., J. Immunol.. 127 (1981) 2381\u20132386.","DOI":"10.4049\/jimmunol.127.6.2381"},{"key":"10.1016\/j.intimp.2019.02.008_bb0160","doi-asserted-by":"crossref","unstructured":"M. Kopf, F. Brombacher, G. K\u00f6hler, G. Kienzle, K. Widmann, K. Lefrang, C. Humborg, B. Ledermann, W. Solbach, IL-4-deficient Balb\/c mice resist infection with Leishmania major., J. Exp. Med.. 184 (1996) 1127\u20131136.","DOI":"10.1084\/jem.184.3.1127"},{"key":"10.1016\/j.intimp.2019.02.008_bb0165","doi-asserted-by":"crossref","unstructured":"Y. Belkaid, C.A. Piccirillo, S. Mendez, E.M. Shevach, D.L. Sacks, CD4+ CD25+ regulatory T cells control Leishmania major persistence and immunity, Nature. 420 (2002) 502.","DOI":"10.1038\/nature01152"},{"key":"10.1016\/j.intimp.2019.02.008_bb0170","doi-asserted-by":"crossref","unstructured":"A. O'Garra, P. Vieira, T H 1 cells control themselves by producing interleukin-10, Nat. Rev. Immunol.. 7 (2007) 425.","DOI":"10.1038\/nri2097"},{"key":"10.1016\/j.intimp.2019.02.008_bb0175","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1084\/jem.20092532","article-title":"IL-10 production differentially influences the magnitude, quality, and protective capacity of Th1 responses depending on the vaccine platform","volume":"207","author":"Darrah","year":"2010","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2019.02.008_bb0180","doi-asserted-by":"crossref","first-page":"669","DOI":"10.4269\/ajtmh.2007.76.669","article-title":"Macrophage killing of Leishmania amazonensis amastigotes requires both nitric oxide and superoxide","volume":"76","author":"Mukbel","year":"2007","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.intimp.2019.02.008_bb0185","doi-asserted-by":"crossref","unstructured":"D.M. Mosser, J.P. Edwards, Exploring the full spectrum of macrophage activation, Nat. Rev. Immunol.. 8 (2008) 958.","DOI":"10.1038\/nri2448"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576918313729?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576918313729?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T16:39:45Z","timestamp":1694623185000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576918313729"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":37,"alternative-id":["S1567576918313729"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2019.02.008","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Host's immune response in unresponsive and responsive patients with anthroponotic cutaneous leishmaniasis treated by meglumine antimoniate: A case-control study of Th1 and Th2 pathways","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2019.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}